Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis
- 31 January 2001
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 44 (1), S17-S27
- https://doi.org/10.1067/mjd.2001.109816
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Topical Application of Tacrolimus Ointment Did Not Alter the Cutaneous Pigmentation of Yucatan MicropigsInternational Journal of Toxicology, 1999
- An Evaluation of the Phototoxicity of Tacrolimus (FK506) Ointment in Hairless MiceInternational Journal of Toxicology, 1998
- Disease Management of Atopic Dermatitis: a Practice ParameterAnnals of Allergy, Asthma & Immunology, 1997
- Atopic dermatitisJournal of the European Academy of Dermatology and Venereology, 1996
- Direct Demonstration of NFATp Dephosphorylation and Nuclear Localization in Activated HT-2 Cells Using a Specific NFATp Polyclonal AntibodyJournal of Biological Chemistry, 1995
- Interaction of Tacrolimus (FK506) and Its Metabolites with FKBP and CalcineurinBiochemical and Biophysical Research Communications, 1994
- Diet-induced dermatitis response of hairless rats to systemic treatment with cyclosporin A (Sandimmun®), cyclosporin H and FK506Experimental Dermatology, 1992
- Human basophil histamine release is differently affected by inhibitors of calmodulin, diacylglycerol kinase and peptidyl prolyl cis‐trans isomerase in a secretagogue specific mannerAllergy, 1992
- Anti-Inflammatory Effects of Macrophilin-lnteracting Drugs in Animal Models of Irritant and Allergic Contact DermatitisInternational Archives of Allergy and Immunology, 1992
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989